MedPage Today on MSN
Complement Inhibitor Slowed Kidney Decline in IgA Nephropathy
Continued FDA approval of iptacopan was contingent on 2-year trial data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results